| NONCODE ID | SNP ID | GWAS trait | Source PMID |
| NONHSAG015852.3 | rs2607045 | Suicide attempts in bipolar disorder (substance abuse/dependence) | 21423239 |
| NONHSAG015852.3 | rs4905631 | Type 2 diabetes | 17463246 |
| NONHSAG015852.3 | rs4905631 | Triglycerides:HDL cholesterol ratio | 17463246 |
| NONHSAG015852.3 | rs2809115 | Mathematical ability | 24801482 |
| NONHSAG015852.3 | rs2616774 | Tourette's syndrome | 22889924 |
| NONHSAG015852.3 | rs2616774 | Tourette syndrome | 22889924 |
| NONHSAG015852.3 | rs2809117 | Gene expression of HEG1 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs2809117 | Lp-PLA2 activity | 20442857 |
| NONHSAG015852.3 | rs2809117 | Multiple complex diseases | 17554300 |
| NONHSAG015852.3 | rs2809117 | Bipolar disorder, combined control dataset | 17554300 |
| NONHSAG015852.3 | rs2809119 | Gene expression of HEG1 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs2809119 | Gene expression of DEF8 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs2809119 | Bipolar disorder, combined control dataset | 17554300 |
| NONHSAG015852.3 | rs2809119 | Multiple complex diseases | 17554300 |
| NONHSAG015852.3 | rs2809119 | Lp-PLA2 activity | 20442857 |
| NONHSAG015852.3 | rs2274818 | Crohn's disease | 17554300 |
| NONHSAG015852.3 | rs2274818 | Multiple complex diseases | 17554300 |
| NONHSAG015852.3 | rs2616767 | Suicide attempts in bipolar disorder (substance abuse/dependence) | 21423239 |
| NONHSAG015852.3 | rs8005571 | Major depressive disorder | 22472876 |
| NONHSAG015852.3 | rs7140601 | Antibody response to smallpox vaccine | 22542470 |
| NONHSAG015852.3 | rs7140601 | Immune response to smallpox vaccine (IL-6) | 22542470 |
| NONHSAG015852.3 | rs12586279 | Autism | 20663923 |
| NONHSAG015852.3 | rs876187 | Transmission distortion | 22377632 |
| NONHSAG015852.3 | rs876187 | Autism | 20663923 |
| NONHSAG015852.3 | rs12887118 | Coronary artery disease (CAD) | 23202125 |
| NONHSAG015852.3 | rs9323980 | Coronary artery disease (CAD) | 23202125 |
| NONHSAG015852.3 | rs8010161 | Type 2 diabetes | 17463246 |
| NONHSAG015852.3 | rs8010161 | Fasting blood glucose | 17463246 |
| NONHSAG015852.3 | rs8013335 | Fasting blood glucose | 17463246 |
| NONHSAG015852.3 | rs8013335 | Type 2 diabetes | 17463246 |
| NONHSAG015852.3 | rs8013518 | Fasting blood glucose | 17463246 |
| NONHSAG015852.3 | rs8013518 | Type 2 diabetes | 17463246 |
| NONHSAG015852.3 | rs4144157 | Coronary artery disease (CAD) | 23202125 |
| NONHSAG015852.3 | rs10142119 | IgE levels in asthmatics (D.f. specific) | 23967269 |
| NONHSAG015852.3 | rs10142119 | IgE levels in asthmatics (D.p. specific) | 23967269 |
| NONHSAG015852.3 | rs1456988 | Graves' disease | 23612905 |
| NONHSAG015852.3 | rs1456988 | Graves' disease | 23612905 |
| NONHSAG015852.3 | rs1456988 | IgE levels in asthmatics (D.f. specific) | 23967269 |
| NONHSAG015852.3 | rs1456988 | Gene expression of C14orf64 in CD4+ T cells | 23612905 |
| NONHSAG015852.3 | rs1350277 | Coronary artery disease (CAD) | 21606135 |
| NONHSAG015852.3 | rs1456992 | Gene expression of CDCA4 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs8019853 | Attention-deficit/hyperactivity disorder (ADHD) | 20732625 |
| NONHSAG015852.3 | rs7143106 | Gene expression of CCDC21 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs12888770 | Fasting insulin | 21901158 |
| NONHSAG015852.3 | rs12888770 | Insulin resistance | 21901158 |
| NONHSAG015852.3 | rs12888770 | HOMA-IR | 21901158 |
| NONHSAG015852.3 | rs12590389 | IgE levels in asthmatics (D.f. specific) | 23967269 |
| NONHSAG015852.3 | rs12892356 | Attention-deficit/hyperactivity disorder (ADHD) | 20732625 |
| NONHSAG015852.3 | rs4900384 | Type 1 diabetes | 19430480 |
| NONHSAG015852.3 | rs4900384 | Type 1 diabetes | 19430480 |
| NONHSAG015852.3 | rs10144042 | Rosuvastatin induced change in lipoprotein-associated phospholipase A2 activity (Lp-PLA2) | 23118302 |
| NONHSAG015852.3 | rs10144042 | Lipoprotein-associated phospholipase A2 activity change in response to statin therapy | 23118302 |
| NONHSAG015852.3 | rs10144042 | Gene expression of RAB11FIP4 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs8015529 | Carotid-femoral pulse wave velocity | 22068335 |
| NONHSAG015852.3 | rs8015529 | Aortic stiffness | 22068335 |
| NONHSAG015852.3 | rs1456975 | Alzheimer's disease (APOE4 homozygotes) | 21379329 |
| NONHSAG015852.3 | rs1456975 | Alzheimer's disease (late onset) | 21379329 |
| NONHSAG015852.3 | rs12589559 | Alzheimer's disease (APOE4 homozygotes) | 21379329 |
| NONHSAG015852.3 | rs12589559 | Alzheimer's disease (late onset) | 21379329 |
| NONHSAG015852.3 | rs4905639 | Gene expression of BAG3 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs857063 | Height | 0 |
| NONHSAG015852.3 | rs857063 | Height | 0 |
| NONHSAG015852.3 | rs857063 | Alzheimer's disease (APOE4 homozygotes) | 21379329 |
| NONHSAG015852.3 | rs857063 | Alzheimer's disease (late onset) | 21379329 |
| NONHSAG015852.3 | rs12436399 | Height | 0 |
| NONHSAG015852.3 | rs857062 | Sodium levels | 0 |
| NONHSAG015852.3 | rs857060 | Attention deficit-hyperactivity disorder (ADHD) hyperactive-impulsive subtype | 23527680 |
| NONHSAG015852.3 | rs857058 | Major depressive disorder | 20081856 |
| NONHSAG015852.3 | rs710285 | Carotid-femoral pulse wave velocity | 22068335 |
| NONHSAG015852.3 | rs698050 | Carotid-femoral pulse wave velocity | 22068335 |
| NONHSAG015852.3 | rs10782490 | Carotid-femoral pulse wave velocity | 22068335 |
| NONHSAG015852.3 | rs61980016 | Colorectal adenoma | 23677573 |
| NONHSAG015852.3 | rs61980016 | Colorectal adenoma (excluding hyperplasic) | 23677573 |
| NONHSAG015852.3 | rs2183623 | Coronary artery disease (CAD) | 21606135 |
| NONHSAG015852.3 | rs17096405 | Monocyte counts | 0 |
| NONHSAG015852.3 | rs17096405 | Coronary artery disease (CAD) | 23202125 |
| NONHSAG015852.3 | rs17773233 | Carotid-femoral pulse wave velocity | 22068335 |
| NONHSAG015852.3 | rs17773233 | Aortic stiffness | 22068335 |
| NONHSAG015852.3 | rs9323989 | Carotid-femoral pulse wave velocity | 22068335 |
| NONHSAG015852.3 | rs7152623 | Aortic stiffness | 22068335 |
| NONHSAG015852.3 | rs7152623 | Carotid-femoral pulse wave velocity | 22068335 |
| NONHSAG015852.3 | rs7152623 | Carotid-femoral pulse wave velocity (age <55) | 22068335 |
| NONHSAG015852.3 | rs7152623 | Carotid-femoral pulse wave velocity (age 55) | 22068335 |
| NONHSAG015852.3 | rs1381289 | Carotid-femoral pulse wave velocity | 22068335 |
| NONHSAG015852.3 | rs1461587 | Carotid-femoral pulse wave velocity | 22068335 |
| NONHSAG015852.3 | rs1461587 | Aortic stiffness | 22068335 |
| NONHSAG015852.3 | rs10400726 | Major depressive disorder (broad definition) (females) | 20038947 |
| NONHSAG015852.3 | rs7160893 | Carotid-femoral pulse wave velocity | 22068335 |
| NONHSAG015852.3 | rs7161307 | Carotid-femoral pulse wave velocity | 22068335 |
| NONHSAG015852.3 | rs1381281 | Staphylococcus aureus infection | 24847357 |
| NONHSAG015852.3 | rs857230 | Myocardial Infarction | 0 |
| NONHSAG015852.3 | rs857230 | Response to anti-TNF treatment for rheumatoid arthritis (change in Disease Activity Score (DAS28)) | 18615156 |
| NONHSAG015852.3 | rs22225442 | Carotid-femoral pulse wave velocity | 22068335 |
| NONHSAG015852.3 | rs2225442 | Aortic stiffness | 22068335 |
| NONHSAG015852.3 | rs987514 | Carotid-femoral pulse wave velocity | 22068335 |
| NONHSAG015852.3 | rs987514 | Aortic stiffness | 22068335 |
| NONHSAG015852.3 | rs987514 | Staphylococcus aureus infection | 24847357 |
| NONHSAG015852.3 | rs10144091 | Response to anti-TNF treatment for rheumatoid arthritis (change in Disease Activity Score (DAS28)) | 18615156 |
| NONHSAG015852.3 | rs7152530 | Staphylococcus aureus infection | 24847357 |
| NONHSAG015852.3 | rs10484128 | Platelet aggregation in response to ADP | 17903294 |
| NONHSAG015852.3 | rs10484128 | Hemostatic factors and hematological phenotypes | 17903294 |
| NONHSAG015852.3 | rs10484128 | Gene expression of LYZL1 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs1381273 | Carotid-femoral pulse wave velocity | 22068335 |
| NONHSAG015852.3 | rs1381273 | Aortic stiffness | 22068335 |
| NONHSAG015852.3 | rs9323992 | Musician's dystonia | 24375517 |
| NONHSAG015852.3 | rs17096688 | Plasma aldosterone concentration | 20877124 |
| NONHSAG015852.3 | rs10484125 | Atopic dermatitis | 21666691 |
| NONHSAG015852.3 | rs17096725 | Glaucoma (normal tension glaucoma) | 22792221 |
| NONHSAG015852.3 | rs857228 | Sexual dysfunction (SSRI/SNRI-related) | 22445761 |
| NONHSAG015852.3 | rs857228 | Selective serotonin reuptake inhibitor/serotonin-noradrenaline reuptake inhibitor-induced sexual dysfunction in subjects with major depression | 22445761 |
| NONHSAG015852.3 | rs857229 | Eur students <30 TrailsA | 20125193 |
| NONHSAG015852.3 | rs857229 | Response to anti-TNF treatment for rheumatoid arthritis (change in Disease Activity Score (DAS28)) | 18615156 |
| NONHSAG015852.3 | rs8181924 | Abnormal Involuntary Movement Scale | 19875103 |
| NONHSAG015852.3 | rs1257907 | Glucose levels | 0 |
| NONHSAG015852.3 | rs1257907 | Glucose levels | 0 |
| NONHSAG015852.3 | rs4905653 | Diabetes Mellitus | 0 |
| NONHSAG015852.3 | rs4905653 | Amyotrophic lateral sclerosis (ALS) age of onset | 22959728 |
| NONHSAG015852.3 | rs1257915 | Simpson-Angus Scale | 19875103 |
| NONHSAG015852.3 | rs1257917 | Glucose levels | 0 |
| NONHSAG015852.3 | rs7157627 | Glucose levels | 0 |
| NONHSAG015852.3 | rs7157627 | Glucose levels | 0 |
| NONHSAG015852.3 | rs11625757 | ZNF667 gene expression in lymphoblastoid cell lines | 19898621 |
| NONHSAG015852.3 | rs11625757 | AraC toxicity as measured by AraC IC50 in lymphoblastoid cell lines | 19898621 |
| NONHSAG015852.3 | rs11625757 | Response to cytadine analogues (cytosine arabinoside) | 24483146 |
| NONHSAG015852.3 | rs1257934 | Childhood intelligence | 23358156 |
| NONHSAG015852.3 | rs1271087 | Serum metabolite (mass spec peak: 807 m/z) | 23281178 |
| NONHSAG015852.3 | rs1271087 | Amyotrophic lateral sclerosis (ALS) | 17362836 |
| NONHSAG015852.3 | rs7149754 | Bipolar disorder | 17486107 |
| NONHSAG015852.3 | rs7149754 | Body Mass Index | 0 |
| NONHSAG015852.3 | rs7149754 | Amyotrophic lateral sclerosis (ALS) age of onset | 22959728 |
| NONHSAG015852.3 | rs7149754 | Longevity (exceptional longevity) | 22279548 |
| NONHSAG015852.3 | rs7155597 | Response to cytadine analogues (cytosine arabinoside) | 24483146 |
| NONHSAG015852.3 | rs10149929 | Serum metabolite (mass spec peak: 807 m/z) | 23281178 |
| NONHSAG015852.3 | rs12880106 | Response to cytadine analogues (cytosine arabinoside) | 24483146 |
| NONHSAG015852.3 | rs4905662 | Body Mass Index | 0 |
| NONHSAG015852.3 | rs4905662 | Amyotrophic lateral sclerosis (ALS) age of onset | 22959728 |
| NONHSAG015852.3 | rs10134920 | Rheumatoid arthritis | 20453842 |
| NONHSAG015852.3 | rs1892234 | Staphylococcus aureus infection | 24847357 |
| NONHSAG015852.3 | rs1959997 | Restenosis after percutaneous coronary intervention | 21878436 |
| NONHSAG015852.3 | rs2186077 | Restenosis after percutaneous coronary intervention | 21878436 |
| NONHSAG015852.3 | rs7492597 | Odorant perception | 23910658 |
| NONHSAG015852.3 | rs11621426 | Response to cytadine analogues (cytosine arabinoside) | 24483146 |
| NONHSAG015852.3 | rs1892231 | Glucose levels | 0 |
| NONHSAG015852.3 | rs1892231 | Glucose levels | 0 |
| NONHSAG015852.3 | rs8015019 | Diabetes Mellitus | 0 |
| NONHSAG015852.3 | rs8015373 | Diabetes Mellitus | 0 |
| NONHSAG015852.3 | rs8015373 | Glucose levels | 0 |
| NONHSAG015852.3 | rs6575651 | Antidepressant efficacy in major depressive disorder improvement after 12 weeks of treatment | 23377640 |
| NONHSAG015852.3 | rs8022740 | Transmission distortion | 22377632 |
| NONHSAG015852.3 | rs8022740 | Personality dimensions | 18957941 |
| NONHSAG015852.3 | rs8022740 | Openness | 18957941 |
| NONHSAG015852.3 | rs8022740 | Maternal transmission distortion | 22377632 |
| NONHSAG015852.3 | rs8022740 | Insulin resistance | 21901158 |
| NONHSAG015852.3 | rs8022740 | HOMA-IR | 21901158 |
| NONHSAG015852.3 | rs8022740 | Fasting insulin | 21901158 |
| NONHSAG015852.3 | rs11621305 | Gene expression of KDELC2 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs11621305 | Treatment outcomes for selective serotonin reuptake inhibitors (SSRIs) - response at last visit | 22907730 |
| NONHSAG015852.3 | rs11621305 | Vaspin levels | 22907691 |
| NONHSAG015852.3 | rs8018467 | Longevity (exceptional longevity) | 22279548 |
| NONHSAG015852.3 | rs1959991 | Obsessive-compulsive disorder (OCD) | 22889921 |
| NONHSAG015852.3 | rs10139819 | Coronary artery disease (CAD) | 23202125 |
| NONHSAG015852.3 | rs967545 | Coronary artery disease (CAD) | 23202125 |
| NONHSAG015852.3 | rs9743626 | Systolic blood pressure in sickle cell anemia | 24058526 |
| NONHSAG015852.3 | rs1888569 | Fasting insulin | 21901158 |
| NONHSAG015852.3 | rs1888569 | Insulin resistance | 21901158 |
| NONHSAG015852.3 | rs1954552 | HOMA-IR | 21901158 |
| NONHSAG015852.3 | rs1954552 | Insulin resistance | 21901158 |
| NONHSAG015852.3 | rs1954552 | Fasting insulin | 21901158 |
| NONHSAG015852.3 | rs7148865 | Myasthenia gravis | 23055271 |
| NONHSAG015852.3 | rs1459128 | Suicide attempts in bipolar disorder (females) | 21423239 |
| NONHSAG015852.3 | rs1888571 | Height | 0 |
| NONHSAG015852.3 | rs1888571 | Height | 0 |
| NONHSAG015852.3 | rs10139457 | HOMA-IR | 21901158 |
| NONHSAG015852.3 | rs10139457 | Fasting insulin | 21901158 |
| NONHSAG015852.3 | rs11160450 | Height | 0 |
| NONHSAG015852.3 | rs1459130 | Rheumatoid arthritis | 20453842 |
| NONHSAG015852.3 | rs11627023 | Aortic root diameter | 21223598 |
| NONHSAG015852.3 | rs8016542 | Suicide attempts in bipolar disorder (males) | 21423239 |
| NONHSAG015852.3 | rs7157095 | PC ae C42:3 / lysoPC a C26:1 | 20037589 |
| NONHSAG015852.3 | rs7157095 | PC ae C42:3 | 20037589 |
| NONHSAG015852.3 | rs1459134 | Multiple complex diseases | 17554300 |
| NONHSAG015852.3 | rs1459134 | Type 2 diabetes, combined control dataset | 17554300 |
| NONHSAG015852.3 | rs7152787 | Myasthenia gravis | 23055271 |
| NONHSAG015852.3 | rs12885202 | Insulin resistance | 21901158 |
| NONHSAG015852.3 | rs12885202 | HOMA-IR | 21901158 |
| NONHSAG015852.3 | rs12890277 | Insulin resistance | 21901158 |
| NONHSAG015852.3 | rs12890277 | HOMA-IR | 21901158 |
| NONHSAG015852.3 | rs11160451 | Gene expression of CRYM in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs1459148 | Extrapyramidal side effects (Simpson-Angus Scale) | 19875103 |
| NONHSAG015852.3 | rs1459148 | Response to antipsychotic therapy (extrapyramidal side effects) | 19875103 |
| NONHSAG015852.3 | rs7155665 | Total cholesterol | 20686565 |
| NONHSAG015852.3 | rs873196 | Alcohol withdrawal symptoms | 22072270 |
| NONHSAG015852.3 | rs1459124 | Alcohol withdrawal symptoms | 22072270 |
| NONHSAG015852.3 | rs1459122 | Total cholesterol | 20686565 |
| NONHSAG015852.3 | rs4905686 | Total cholesterol | 20686565 |
| NONHSAG015852.3 | rs1380206 | HDL cholesterol | 20339536 |
| NONHSAG015852.3 | rs9944040 | Total cholesterol | 20686565 |
| NONHSAG015852.3 | rs4905688 | Total cholesterol | 20686565 |
| NONHSAG015852.3 | rs2150506 | Total cholesterol | 20686565 |
| NONHSAG015852.3 | rs4900400 | Total cholesterol | 20686565 |
| NONHSAG015852.3 | rs1459143 | HDL cholesterol | 20339536 |
| NONHSAG015852.3 | rs8016978 | Total cholesterol | 20686565 |
| NONHSAG015852.3 | rs12590880 | Gene expression of MSTP9 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs12432948 | HDL cholesterol | 20339536 |
| NONHSAG015852.3 | rs7146949 | Schizophrenia | 20185149 |
| NONHSAG015852.3 | rs11623690 | Lung function, predicted ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC) | 19300500 |
| NONHSAG015852.3 | rs11623690 | Autism with high IQ | 20663923 |
| NONHSAG015852.3 | rs2125598 | LDL cholesterol | 20686565 |
| NONHSAG015852.3 | rs2125598 | Total cholesterol | 20686565 |
| NONHSAG015852.3 | rs10141191 | Alcohol withdrawal symptoms | 22072270 |
| NONHSAG015852.3 | rs7161221 | Alcohol withdrawal symptoms | 22072270 |
| NONHSAG015852.3 | rs7144421 | Gene expression of THSD7A in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs1952863 | Large vessel stroke | 17434096 |
| NONHSAG015852.3 | rs74504540 | Atopic dermatitis | 23042114 |
| NONHSAG015852.3 | rs77327972 | Atopic dermatitis | 23042114 |
| NONHSAG015852.3 | rs74531464 | Atopic dermatitis | 23042114 |
| NONHSAG015852.3 | rs143048407 | Atopic dermatitis | 23042114 |
| NONHSAG015852.3 | rs1380212 | Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants) | 22424883 |
| NONHSAG015852.3 | rs1380212 | Decrease in FEV1 (in asthmatic participants >=30 years old) | 22424883 |
| NONHSAG015852.3 | rs6575671 | Alzheimer's disease | 17998437 |
| NONHSAG015852.3 | rs10139309 | Alzheimer's disease | 17998437 |
| NONHSAG015852.3 | rs4503728 | Autism without verbal ability | 20663923 |
| NONHSAG015852.3 | rs2776496 | Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants) | 22424883 |
| NONHSAG015852.3 | rs2776496 | Decrease in FEV1 (in asthmatic participants >=30 years old) | 22424883 |
| NONHSAG015852.3 | rs2776498 | Alzheimer's disease | 17998437 |
| NONHSAG015852.3 | rs2753971 | Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants) | 22424883 |
| NONHSAG015852.3 | rs2753971 | Decrease in FEV1 (in asthmatic participants >=30 years old) | 22424883 |
| NONHSAG015852.3 | rs17096988 | Bipolar disorder in alcoholics | 21876473 |
| NONHSAG015852.3 | rs7492339 | Adiponectin levels | 22479202 |
| NONHSAG015852.3 | rs17097036 | Gene expression of SLC16A2 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs17097036 | Bipolar disorder in alcoholics | 21876473 |
| NONHSAG015852.3 | rs1956849 | Total serum IgE | 18846228 |
| NONHSAG015852.3 | rs8003296 | Acetate:trans-Aconitate | 21572414 |
| NONHSAG015852.3 | rs8003296 | Prostate cancer mortality | 20978177 |
| NONHSAG015852.3 | rs8003296 | Aortic root diameter | 21223598 |
| NONHSAG015852.3 | rs17097056 | Lp-PLA2 activity | 20442857 |
| NONHSAG015852.3 | rs7161086 | Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) | 20877124 |
| NONHSAG015852.3 | rs7161086 | Plasma aldosterone concentration corrected by plasma renin activity | 20877124 |
| NONHSAG015852.3 | rs7161086 | Plasma aldosterone concentration | 20877124 |
| NONHSAG015852.3 | rs7161086 | Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) | 20877124 |
| NONHSAG015852.3 | rs17097078 | Methylation levels at chr14:75058450-75058500 [hg18 coord, probe cg15645309] in Caudal pons | 20485568 |
| NONHSAG015852.3 | rs17097084 | Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) | 20877124 |
| NONHSAG015852.3 | rs17097084 | Plasma aldosterone concentration corrected by plasma renin activity | 20877124 |
| NONHSAG015852.3 | rs17097084 | Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) | 20877124 |
| NONHSAG015852.3 | rs17097084 | Plasma aldosterone concentration | 20877124 |
| NONHSAG015852.3 | rs17097087 | Gene expression of SLC16A2 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs17097087 | Bipolar disorder in alcoholics | 21876473 |
| NONHSAG015852.3 | rs17097087 | Stabilized warfarin dose | 18535201 |
| NONHSAG015852.3 | rs17097094 | Plasma aldosterone concentration corrected by plasma renin activity | 20877124 |
| NONHSAG015852.3 | rs17097094 | Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) | 20877124 |
| NONHSAG015852.3 | rs17097094 | Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) | 20877124 |
| NONHSAG015852.3 | rs17097094 | Plasma aldosterone concentration | 20877124 |
| NONHSAG015852.3 | rs1951102 | Gene expression of SBNO1 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs1951102 | Gene expression of TBRG1 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs1951102 | Gene expression of UBA2 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs1951102 | Gene expression of ALDH1B1 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs11160463 | Cystatin C in serum | 20383146 |
| NONHSAG015852.3 | rs8022320 | Prostate cancer mortality | 20978177 |
| NONHSAG015852.3 | rs8022320 | Prostate cancer mortality | 20978177 |
| NONHSAG015852.3 | rs10139212 | Arginine:Sucrose | 21572414 |
| NONHSAG015852.3 | rs10139212 | serum glucose:Asparagine | 21572414 |
| NONHSAG015852.3 | rs11850908 | Arginine:Sucrose | 21572414 |
| NONHSAG015852.3 | rs11850908 | Gene expression of SLC41A1 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs10138364 | Arginine:Sucrose | 21572414 |
| NONHSAG015852.3 | rs10138364 | Gene expression of SLC41A1 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs10151617 | Gene expression of LPP in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs10151617 | White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy | 24578207 |
| NONHSAG015852.3 | rs10132593 | Gene expression of BBS2 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs10146427 | Gene expression of SLC41A1 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs17097169 | Urinary albumin-to-creatinine ratio | 21355061 |
| NONHSAG015852.3 | rs8010530 | Gene expression of SLC41A1 in peripheral blood monocytes | 20502693 |
| NONHSAG015852.3 | rs17595289 | Glucose:Isopropanol | 21572414 |